First Horizon Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.28 Billion
- Q2 2024
A detailed history of First Horizon Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 34 shares of HRMY stock, worth $1,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34Holding current value
$1,186% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
233Shares Held
45.2MCall Options Held
48.2KPut Options Held
56.5K-
Valor Management LLC Chicago, IL11.2MShares$392 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$123 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$91 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$87.6 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.07B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...